David J. Marmion

T cell infiltration in both human multiple system atrophy and a novel mouse model of the disease

Gregory P. Williams, David J. Marmion, Aubrey M. Schonhoff et al. · Acta Neuropathologica · 2020 · 92 citations · Full text

Robust graft survival and normalized dopaminergic innervation do not obligate recovery in a <scp>P</scp>arkinson disease patient

Jeffrey H. Kordower, Christopher G. Goetz, Yaping Chu et al. · Annals of Neurology · 2016 · 88 citations

Transplantation Medicine, Clinical Neurology, Neurological Progress +27

Cryopreservation Maintains Functionality of Human iPSC Dopamine Neurons and Rescues Parkinsonian Phenotypes In Vivo

Dustin R. Wakeman, Benjamin M. Hiller, David J. Marmion et al. · Stem Cell Reports · 2017 · 81 citations · Full text

Neurotransmitter, Midbrain Lineage, Neurotransmission +22

Optimizing maturity and dose of iPSC-derived dopamine progenitor cell therapy for Parkinson’s disease

Benjamin M. Hiller, David J. Marmion, Cayla A. Thompson et al. · npj Regenerative Medicine · 2022 · 66 citations · Full text

Novel oligodendroglial alpha synuclein viral vector models of multiple system atrophy: studies in rodents and nonhuman primates

Ronald J. Mandel, David J. Marmion, Deniz Kirik et al. · Acta Neuropathologica Communications · 2017 · 57 citations · Full text

Neurogenomics, Synaptic Transmission, Multiple System Atrophy +24